Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial

Hinks TSC., Cureton L., Knight R., Wang A., Cane JL., Barber VS., Black J., Dutton SJ., Melhorn J., Jabeen M., Moss P., Garlapati R., Baron T., Johnson G., Cantle F., Clarke D., Elkhodair S., Underwood J., Lasserson D., Pavord ID., Morgan S., Richards D.

DOI

10.1016/s2213-2600(21)00263-0

Type

Journal article

Journal

The Lancet Respiratory Medicine

Publisher

Elsevier BV

Publication Date

10/2021

Volume

9

Pages

1130 - 1140

Permalink Original publication